Adenoviral vector + cytomegalovirus (Ad5-CMV) |
Antisense-TGF-β1 mRNA |
TGF-β synthesis in cultured HSCs |
Abrogates TGF-β enhanced production of collagen and α-SMA |
80 |
Adenoviral vector |
Human urokinase plasminogen activator cDNA |
Latent hepatic collagenases |
Reduced α-Sma, increased Mmp-2, stimulated liver regeneration |
98 |
Adenovirus + HBV vector (chimeric Ad-HBV shuttle vector) |
Truncated MMP-8 gene (tMMP8) |
HGF |
Induced hepatocyte proliferation in liver cells without affecting other tissues |
99 |
Adenoviral vector |
HGF-encoding cDNA |
Fibrogenic cytokines PDGF-bb and TGF-β1 |
Elevated HGF levels in the portal vein, decreased collagen level |
100 |
Recombinant lentivirus particles |
Artificial miRNAs |
Pdgfrβ and Tgfbr2
|
Co-knockdowns the expressions of Tgfbr2 and Pdgfrβ, suppressed expressions of α-Sma, Col1a1, Mmps and Timp1
|
101 |
Recombinant adenoviral vector |
β-Galactosidase |
Hepatocytes |
Decreased the expression of hepatocytes |
102 |
Recombinant adenoviral vector |
MMP-1 |
Hepatocytes |
Decreased the number of activated HSCs, and increased hepatocyte proliferation |
103 |
Recombinant adenoviral vector |
MMP-8 |
Hepatocytes |
Diminished hydroxyproline content, and up regulated expression of MMP-2 and MMP-3
|
104 |
Adeno-associated virus |
ACE2 |
Hepatic ACE2 and angiotensin II |
Reduction of angiotensin II, and inflammatory cytokine expression |
105 |
Adeno-associated virus |
Bone morphogenetic protein-7 (Bmp-7) |
Tgfb |
Long-term elevation of serum Bmp-7 concentrations and amelioration of CCl4-induced hepatic fibrosis |
106 |
Adeno-associated virus |
miR-221-3p |
Hepatocytes |
Faster resolution of the deposited ECM, and reduced secretion of C-C motif chemokine ligand 2 |
|
Hemagglutinating virus of Japan (HVJ) |
Oncostatin M (OSM) cDNA |
OSM protein in KCs |
Reduced centrilobular necrosis and inflammatory cell infiltration, augmented hepatocyte proliferation, and suppressed hepatocytes apoptosis and fibrosis |
107 |
Recombinant simian virus 40 vector (rSV40) |
Recombinant insulin-like growth factor I (rIGF-I) |
rIGF-I receptor |
Reduced serum bilirubin, transaminases and liver fibrosis score, and increased expression of Hgf and Mmps
|
108 |
Minicircle vector (MC-hALR) |
Regeneration/growth factor ERV1-like (ALR/GFER) gene |
Tgfb, Pdgfb, α-Sma |
Suppressed production of collagen I and α-Sma, Tgfb, Pdgfb, alleviated liver injury and fibrosis in rats |
109 |
Plasmid |
Artificial miRNA |
CTGF, TGF-β1
|
Reduced hepatic fibrosis, and decreased levels of collagen I and α-SMA |
110 |
Graphene-dendrimer nanostar |
Plasmid encoding for the collagenase MMP-9 |
Macrophages |
Promoted macrophage switch from inflammatory M1 to pro-regenerative M2 in three days |
111 |
pCMV-Luc plasmid |
Mmp-13 gene |
Hepatocytes |
Reduced liver fibrosis, and improved efficiency of hydrodynamic gene delivery |
93 |
psiCHECK-2 |
miR-378a-3p, miR-378b, miR-378d |
Gli3 in activated HSC |
Accelerated expression of fibrotic genes and hedgehog signaling pathway |
112 |
Lentivirus |
miR-122 |
Type I collagen |
Decreased collagen, Fn1 and Srf levels in the liver of CCl4-treated mice |
113 |
Lentivirus |
miRNA-101 family members |
– |
Attenuated profibrogenic Tgfb signalling and suppressed Tgfb-induced hepatocyte apoptosis and the inhibited cell proliferation |
91 |
Lentivirus |
Atp7b gene |
Copper transport protein |
Lowered liver copper levels, and decreased fibrotic tissue |
114 |
Lentivirus |
MiR-542-3p |
BMP-7 |
Reduced liver fibrosis |
115 |
pPB-modified stable nucleic acid LNPs |
siRNA |
Heat shock protein 47 |
Inhibitory effect on TAA-induced hepatic fibrosis with high gp46 mRNA expression |
116 |
Poly (lactide-co-glycolide)-polyspermine-poly (ethylene glycol)-vitamin A (PLGA-PSPE-PEG-VA) |
Co-delivery of silibinin and siCol1α1 |
Activated HSCs |
Targeted activated HSCs specifically, decreased collagen I production and ameliorated liver fibrosis |
117 |
CXCR4-targeted NPs |
CXCR4+ sorafenib and MEK inhibitor |
ERK in activated HSCs |
Prevented activation of ERK in activated HSCs, anti-fibrotic effects in the CCl4-induced murine model |
118 |
Ultrasound-targeted microbubbles |
HGF |
Collagen I and HGF |
HGF delivery into the fibrotic liver and production of an anti-fibrosis effect |
79 |
CSLNs |
siCtgf |
Pro-fibrotic genes in HSCs |
Reduced collagen content Tnfa, Tgfb, IL-6, and Ctgf significantly, improved pathophysiological symptoms in rats |
119 |
VA-polyethylene glycol polyethyleneimine-poly(N-(N′,N′-diisopropylaminoethyl)-co-benzylamino) aspartamide |
miRNA-29b and miRNA-122 |
HSC |
Improved liver function, and relieved hepatic fibrosis |
120 |
Poly(amine-co-ester) NPs |
Nogo-B siRNA |
Liver |
Suppressed Nogo-B protein in the liver up to 60% after systemic administration |
121 |